ETST Q1 Revenue Reaches $9M, Net Income $716K; Buyback Continues, CEO Voting Control Revealed
ETST filed a Earnings and Guidance on elevated volume (4.9× avg).
Summary
Earth Science Tech reported Q1 FY2027 revenue of $9.03M and net income of $716K, repurchased 3.7M shares, and disclosed CEO voting control via Series B Preferred Stock.
Key Events · Earnings and Guidance · ETST
-
Q1 Revenue $9.03M, Net Income $716K
Revenue increased 3% YoY to $9,025,779; net income available to common stockholders was $724,192, or $0.003 per share, compared to $465,039 a year ago.
-
Share Repurchase: 3.7M Shares Retired
The company spent $392,191 to repurchase and retire 3,733,726 shares during the quarter, reducing outstanding shares to 287.6 million.
-
CEO Voting Control via Series B Preferred
The CEO holds all outstanding Series B Preferred Stock, which carries 150% voting power relative to common stock, giving him voting control over all shareholder matters including the upcoming annual meeting.
-
No Dilutive Financing Since Early 2023
Management reiterated its commitment to non-dilutive growth; no equity securities have been sold since early 2023, and authorized common shares were previously reduced from 750M to 300M.
Analysis · ETST · Life Sciences
Earth Science Tech delivered $9.03 million in quarterly revenue, a 3% year-over-year increase, alongside net income of $715,697. During the quarter, 3.7 million shares were repurchased and retired for $392,191, extending the company's non-dilutive capital allocation strategy. The filing also discloses that the CEO holds super-voting preferred stock conferring 150% voting power, which solidifies insider control ahead of the August 31 annual meeting where a controversial reverse split proposal is on the ballot. For a micro-cap name, the mix of steady operations, ongoing buybacks, and concentrated governance makes this a notable update.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 29.4% of the 1560 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ETST was trading at $0.09 on OTC in the Life Sciences sector, with a market capitalization of approximately $26.7M. The 52-week trading range was $0.00 to $0.24. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.